Angiogenesis, programmed death ligand 1 (PD-L1) and immune microenvironment association in laryngeal carcinoma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Angiogenesis, programmed death ligand 1 (PD-L1) and immune microenvironment association in laryngeal carcinoma
Authors
Keywords
-
Journal
PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-05-14
DOI
10.1016/j.pathol.2021.02.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle
- (2020) Yuan Zhuang et al. OncoTargets and Therapy
- Maspin expression and anti-apoptotic pathway regulation by bcl2 in laryngeal cancer
- (2020) Andrea Lovato et al. Annals of Diagnostic Pathology
- Biological tumor markers (maspin, CD105, nm23-H1) and disease relapse in laryngeal cancer: cluster analysis
- (2020) Leonardo Franz et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma
- (2020) Gino Marioni et al. Cancers
- Synergies of Antiangiogenic Therapy and Immune Checkpoint Blockade in Renal Cell Carcinoma: From Theoretical Background to Clinical Reality
- (2020) Xiaohan Zhou et al. Frontiers in Oncology
- CD105- and CD31-assessed microvessel density in laryngeal carcinoma biopsies as a predictor of recurrence after exclusive primary surgery
- (2020) Leonardo Franz et al. Annals of Diagnostic Pathology
- Immunotherapy combinations for the treatment of patients with solid tumors
- (2020) Maria Virginia Bluthgen et al. Future Oncology
- Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma
- (2020) Lara Alessandrini et al. ORAL ONCOLOGY
- Postoperative radiotherapy for laryngeal cancer. The prognostic role of programmed death-ligand 1: An immune microenvironment-based cluster analysis
- (2020) Leonardo Franz et al. PATHOLOGY RESEARCH AND PRACTICE
- Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
- (2020) Yuxiao Song et al. Frontiers in Immunology
- Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer
- (2020) Leonardo Franz et al. Annals of Diagnostic Pathology
- Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- (2019) Ming Yi et al. Molecular Cancer
- Anti-VEGF/VEGFR2 monoclonal antibodies and their combinations with PD-1/PD-L1 inhibitors in clinic
- (2019) Feng Gao et al. CURRENT CANCER DRUG TARGETS
- Preclinical rationale and clinical efficacy of antiangiogenic therapy and immune checkpoint blockade combination therapy in urogenital tumors
- (2019) Ning Zhu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- Tumor microenvironment components: Allies of cancer progression
- (2019) Pablo Igor Ribeiro Franco et al. PATHOLOGY RESEARCH AND PRACTICE
- CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma
- (2018) Anke Schlüter et al. BMC CANCER
- Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer†
- (2018) Giovanna Armani et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
- (2018) Maria Georganaki et al. Frontiers in Immunology
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- The non-canonical role of vascular endothelial growth factor-C axis in cancer progression
- (2015) Chu-An Wang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Vascular Endothelial Growth Factor C Disrupts the Endothelial Lymphatic Barrier to Promote Colorectal Cancer Invasion
- (2015) Carlotta Tacconi et al. GASTROENTEROLOGY
- Targeting angiogenesis in head and neck cancer
- (2015) Maria Vassilakopoulou et al. ORAL ONCOLOGY
- Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma
- (2015) Patcharee Ritprajak et al. ORAL ONCOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
- (2014) K. A. Schalper et al. CLINICAL CANCER RESEARCH
- Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
- (2014) Joseph M. Curry et al. SEMINARS IN ONCOLOGY
- Indications for postoperative radiotherapy in laryngeal carcinoma: A panel of tumor tissue markers for predicting locoregional recurrence in surgically treated carcinoma. A pilot study
- (2013) Gino Marioni et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Potential prognostic and therapeutic role for angiogenesis markers in laryngeal carcinoma
- (2012) Marco Lionello et al. ACTA OTO-LARYNGOLOGICA
- Letter to the editors: Essentials for an updated epidemiology of laryngeal carcinoma
- (2012) Gino Marioni CANCER TREATMENT REVIEWS
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Neoangiogenesis in laryngeal carcinoma: angiogenin and CD105 expression is related to carcinoma recurrence rate and disease-free survival
- (2010) Gino Marioni et al. HISTOPATHOLOGY
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now